Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss medications. Lilly filed four lawsuits on Wednesday claiming telehealth ...

Eli Lilly said its phase 3 trial of GLP-1 drug in pill form found results similar to popular injectables for weight loss. Orforglipron would be used as a daily pill, eliminating the need for ...

Eli Lilly's shares were rallying ahead of the opening bell after the drug company's first GLP-1 pill for diabetes and weight ... the first oral small molecule glucagon-like peptide-1, or GLP ...

Eli Lilly and Company (NYSE ... adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone. Orforglipron is the first oral small molecule glucagon-like peptide ...

It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE ... and effectiveness for treating both diabetes and obesity, with no need for injections. The company is therefore still a ways ...

Eli Lilly and Company announced on Friday positive topline Phase 3 results from ACHIEVE-1, evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and ...

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide ... diseases like type 2 diabetes, which is expected to impact ...

Eli Lilly and Company ... and glucagon-like peptide-1 (GLP-1) mimetic, which is marketed and sold as Zepbound in the indication of weight loss, and as Mounjaro in the indication of Type 2 Diabetes.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... pharmacies from making copies of its weight-loss and diabetes medicines. Compounders were, until recently ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India ... insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, helping regulate ...